Add to ORKGThe Author(s) 2013. This article is published with open access at Springerlink.com Introduction: CHOICE (CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE therapy; NCT00635492) assessed, as its primary objective, the time to a ‘significant treatment change ’ (defined withi
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-la...
Thesis (M.Nurs.), College of Nursing, Washington State UniversityThe prevalence of type 2 diabetes c...
injections for patients with type 2 diabetes mellitus who have poor glycemic control despite taking ...
CHOICE (CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE the...
The CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE therapy...
International audienceBACKGROUND: Improvements in the clinical condition of patients with type 2 dia...
CHOICE (CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE the...
Abstract: Type 2 diabetes remains an escalating problem worldwide, despite a range of treatments bei...
Type 2 diabetes remains an escalating world-wide problem, despite a range of treatments. The revela...
Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin g...
Katherine V Mann,1 Philip Raskin2 1PharmD Consulting, LLC, Royal Oak, MD, USA; 2Department of Intern...
Exenatide once-weekly is effective, well tolerated in patients with T2DM and should be a useful addi...
Introduction Investigate the effects of switching from two times per day exenatide to once-weekly ex...
Peggy Soule Odegard1, Anthony DeSantis21School of Pharmacy, 2Division of Metabolism, Endocrinology a...
the safety and efficacy of 30 weeks of treatment with the glucagon-like peptide-1 receptor agonist e...
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-la...
Thesis (M.Nurs.), College of Nursing, Washington State UniversityThe prevalence of type 2 diabetes c...
injections for patients with type 2 diabetes mellitus who have poor glycemic control despite taking ...
CHOICE (CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE the...
The CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE therapy...
International audienceBACKGROUND: Improvements in the clinical condition of patients with type 2 dia...
CHOICE (CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE the...
Abstract: Type 2 diabetes remains an escalating problem worldwide, despite a range of treatments bei...
Type 2 diabetes remains an escalating world-wide problem, despite a range of treatments. The revela...
Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin g...
Katherine V Mann,1 Philip Raskin2 1PharmD Consulting, LLC, Royal Oak, MD, USA; 2Department of Intern...
Exenatide once-weekly is effective, well tolerated in patients with T2DM and should be a useful addi...
Introduction Investigate the effects of switching from two times per day exenatide to once-weekly ex...
Peggy Soule Odegard1, Anthony DeSantis21School of Pharmacy, 2Division of Metabolism, Endocrinology a...
the safety and efficacy of 30 weeks of treatment with the glucagon-like peptide-1 receptor agonist e...
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-la...
Thesis (M.Nurs.), College of Nursing, Washington State UniversityThe prevalence of type 2 diabetes c...
injections for patients with type 2 diabetes mellitus who have poor glycemic control despite taking ...